Wealthspire Advisors, LLC Mereo Biopharma Group PLC Transaction History

Wealthspire Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$1.04 - $1.7 $20,047 - $32,769	-19,276 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.59 $29,106 - $49,924	19,276 New	19,276 $31,000
Q3 2021 Nov 15, 2021	SELL	$2.2 - $3.17 $31,407 - $45,254	-14,276 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.95 - $3.6 $27,838 - $51,393	14,276 New	14,276 $51,000
Q2 2020 Aug 14, 2020	SELL	$1.0 - $3.4 $14,276 - $48,538	-14,276 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$0.8 - $3.21 $11,420 - $45,825	14,276 New	14,276 $15,000

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $376M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthspire Advisors, LLC with notifications on news.